Диапазон
€156.77
Live · Q4 2026Пазарите в ЕС —
Пазарите в ЕС —
в един поток.
Информационният слой зад B2B платформата на ViraChem. Актуални спот цени, новини за R&D от отворени регистри и практически проучвания за фармацевтични и биотехнологични лаборатории в цяла Европа — директно от нашата търговска мрежа и обновявани всеки час.
/ 02 Спот цени
Актуални цени и анализ/ 7-day spot · €/g · 24 compounds
Обновявано на всеки часВсички съединения →
BPC-157 acetate · In Vivo
7d
€/g
€/g
€156/g▼~-5.5%
−30d−20d−10dсега
HPLC чистота
≥98%
Grade
In Vivo
GHK-cu acetate · In Vivo
7d
€/g
€/g
€4/g▼~-3.5%
−30d−20d−10dсега
Диапазон
€4.39
HPLC чистота
≥98%
Grade
In Vivo
Mots-c acetate · In Vivo
7d
€/g
€/g
€277/g▼~-4.8%
−30d−20d−10dсега
Диапазон
€274.36
HPLC чистота
≥98%
Grade
In Vivo
CJC 1295 NO DAC acetate · In Vivo
7d
€/g
€/g
€512/g▼~-1.4%
−30d−20d−10dсега
Диапазон
€509.52
HPLC чистота
≥98%
Grade
In Vivo
Съединение · химия
7-дневна тенденция
€/g · спот
1d · 7d · 30d
HPLC чистота
BPCBPC-157 acetate· raw powder
In Vivoacetate
CAS137525-51-0MW1419.5 g/molСолacetateCID9941957SEQGEPPPGKPADDAGLVInChIHEEWEZGQMLZMFE-RKGINYAYSA-N
€156/g
1d~+2.6%7d▼ ~-5.5%30d~+11.1%
≥98%
GHKGHK-cu acetate· raw powder
In Vivoacetate
CAS89030-95-5MW401.91 g/molСолacetateCID139035031SEQGly-His-Lys (Cu²⁺)InChILREZPQNYQZAPJC-ACMTZBLWSA-L
€4/g
1d~-0.7%7d▼ ~-3.5%30d~-11.2%
≥98%
MOTMots-c acetate· raw powder
In Vivoacetate
CAS1627580-64-6MW2174.6 g/molСолacetateCID146675088SEQMRWQEMGYIFYPRKLRInChIWYTHCOXVWRKRAH-LOKRTKBUSA-N
€277/g
1d~-1.3%7d▼ ~-4.8%30d~-2.8%
≥98%
CJCCJC 1295 NO DAC acetate· raw powder
In Vivoacetate
CAS863288-34-0MW3367.9 g/molСолacetateCID56841945SEQY-(D-A)-D-A-I-F-T-Q-S-Y-R-K-V-L-A-Q-L-S-A-R-K-L-L-Q-D-I-L-S-R-NH2InChIXOZMWINMZMMOBR-HRDSVTNWSA-N
€512/g
1d~+1.6%7d▼ ~-1.4%30d~+14.2%
≥98%
EPIEpithalon acetate· raw powder
Industrialacetate
CAS64082-79-7MW390.35 g/molСолacetateCID219042SEQAEDGInChIHGHOBRRUMWJWCU-FXQIFTODSA-N
€105/g
1d~+0.5%7d▲ ~+9.3%30d~+3.2%
>90%
THYThymosin alpha 1 acetate· raw powder
In Vivoacetate
CAS62304-98-7MW3108.3 g/molСолacetateCID16130571SEQSDAAVDTSSEITTKDLKEKKEVVEEAENInChINZVYCXVTEHPMHE-ZSUJOUNUSA-N
€562/g
1d~-2.2%7d▼ ~-5.7%30d~-4.6%
≥98%
THY3Thymulin acetate· raw powder
Industrialacetate
CAS63958-90-7MW858.9 g/molСолacetateCID71300623SEQXAKSQGGSNInChILIFNDDBLJFPEAN-YTAPOSPOSA-N
€165/g
1d~-0.2%7d▼ ~-4.5%30d~-6.0%
>90%
AMI5-Amino 1MQ chloride· raw powder
In Vivochloride
CAS685079-15-6MW159.21 g/molСолchlorideCID950107InChIZMJBCEIHNOWCMC-UHFFFAOYSA-O
€2/g
1d~+3.3%7d▼ ~-2.4%30d~-9.1%
≥98%
AODAOD-9604 acetate· raw powder
In Vivoacetate
CAS221231-10-3MW1815.1 g/molСолacetateCID71300630SEQYLRIVQCRSVEGSCGFInChIGVIYUKXRXPXMQM-BPXGDYAESA-N
€874/g
1d~-1.6%7d▼ ~-5.4%30d~-9.8%
≥98%
DSIDSIP acetate· raw powder
In Vivoacetate
CAS62568-57-4MW848.8 g/molСолacetateCID68816SEQWAGGDASGEInChIZRZROXNBKJAOKB-GFVHOAGBSA-N
€196/g
1d~+3.7%7d▲ ~+7.9%30d~+10.4%
≥98%
IPAIpamorelin acetate· raw powder
In Vivoacetate
CAS170851-70-4MW711.9 g/molСолacetateCID9831659SEQXHXFKInChINEHWBYHLYZGBNO-BVEPWEIPSA-N
€243/g
1d~-0.9%7d▼ ~-4.8%30d~+5.3%
≥98%
KPV
KPVKPV acetate· raw powder
In Vivo
€223/g
1d~+0.1%7d▼ ~-1.7%30d~-7.5%
≥98%
KISKisspeptin-10 acetate· raw powder
In Vivoacetate
CAS374675-21-5MW1302.4 g/molСолacetateCID25240297SEQYNWNSFGLRFInChIRITKWYDZSSQNJI-INXYWQKQSA-N
€285/g
1d~-3.1%7d▼ ~-5.3%30d~-4.3%
≥98%
LLALL-37 acetate· raw powder
In Vivoacetate
CAS154947-66-7MW4493 g/molСолacetateCID16198951SEQLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESInChIPOIUWJQBRNEFGX-XAMSXPGMSA-N
€774/g
1d~+2.8%7d▲ ~+3.7%30d~+0.3%
≥98%
MELMelanotan 2 acetate· raw powder
Industrialacetate
CAS121062-08-6MW1024.18 g/molСолacetateCID92432SEQXDHFRWKInChIJDKLPDJLXHXHNV-MFVUMRCOSA-N
€162/g
1d~-3.7%7d▲ ~+5.7%30d~+12.6%
>90%
NADNAD+· raw powder
In Vivo
CAS53-84-9MW663.4 g/molCID5892InChIBAWFJGJZGIEFAR-NNYOXOHSSA-N
€1/g
1d~+4.7%7d▲ ~+8.5%30d~+8.5%
≥98%
PEG
PEGPEG-MGF acetate· raw powder
In Vivoacetate
MW4888 g/molСолacetateSEQYQPPSTNKNTKSQRRKGSTFEERK-NH2
€1,380/g
1d~+1.4%7d▲ ~+11.0%30d~+14.9%
≥98%
PTAPT-141 acetate· raw powder
In Vivoacetate
CAS189691-06-3MW1025.2 g/molСолacetateCID9941379SEQXDHFRWKInChIFFHBJDQSGDNCIV-MFVUMRCOSA-N
€378/g
1d~0.0%7d▲ ~+6.3%30d~+0.4%
≥98%
RETRetatrutide acetate· raw powder
In Vivoacetate
CAS2381089-83-2MW4731.33 g/molСолacetateCID171390338SEQY-Aib-QGTFTSDYSI-αMeLeu-LDK-Lys(19-carboxy-nonadecanoyl-γGlu-AEEA)-AQ-Aib-AFIEYLLEGGPSSGAPPPS-NH₂InChIMLOLQJNKXBNWFW-SAGGEDDASA-N
€164/g
1d~-3.6%7d▼ ~-8.2%30d~-12.4%
≥98%
SS3SS-31 acetate· raw powder
In Vivoacetate
CAS736992-21-5MW639.8 g/molСолacetateCID11764719SEQRXKFInChISFVLTCAESLKEHH-WKAQUBQDSA-N
€329/g
1d~+2.6%7d▲ ~+11.0%30d~+2.0%
≥98%
SELSelank acetate· raw powder
In Vivoacetate
CAS129954-34-3MW751.9 g/molСолacetateCID11765600SEQTKPRPGPInChIJTDTXGMXNXBGBZ-YVHUGQOKSA-N
€187/g
1d~+1.7%7d▼ ~-0.9%30d~-9.1%
≥98%
SEMSemax acetate· raw powder
In Vivoacetate
CAS80714-61-0MW813.9 g/molСолacetateCID9811102SEQMEHFPGPInChIAFEHBIGDWIGTEH-AQRCPPRCSA-N
€192/g
1d~+1.4%7d▲ ~+2.9%30d~+9.5%
≥98%
TESTesamorelin acetate· raw powder
In Vivoacetate
CAS218949-48-5MW5136 g/molСолacetateCID16137828SEQYADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARLInChIQBEPNUQJQWDYKU-BMGKTWPMSA-N
€541/g
1d~+1.4%7d▲ ~+5.8%30d~+3.0%
≥98%
THY4Thymosin beta-4 acetate· raw powder
In Vivoacetate
CAS77591-33-4MW4963 g/molСолacetateCID45382195SEQSDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGESInChIUGPMCIBIHRSCBV-UHFFFAOYSA-N
€571/g
1d~+0.6%7d▲ ~+2.3%30d~-2.1%
≥98%
Prices derive from ViraChem’s active network of trade, converted to EUR at the ECB daily reference rate for each transaction date. Методология →
24 compounds·€/g·ECB · EUR/USD 1.1188·Updated 07:59 CET·Q4 2026
/ 03 Пулс на новините
Новинарски пулс и последни изследвания/ отворени регистри · блог
Обновявано на всеки часЦялата емисия →
Емисия с R&D новиниEUROPE PMC · CT.GOV
13 OCT
ПрепринтbioRxiv· immunology
Self-reactive human CD8⁺ T cells restricted by HLA-E mediate immunoregulatory and antiviral functions
HLA-E constitutively presents self VL9 peptides on healthy cells, signaling an intact HLA class I pathway and protecting cells from natural killer cell attack. Beyond this canonical role, HLA-E-restricted CD8 T cells …
Walters, L. C.; Guo, X.; Casquero, C.; Urbach, J. M.; Leddy, O.; Cakan, E.; Chan, A. O.; Balivada, P. A.; Wisner, H.; Bryson, B. D.; Whit…
13 OCT
Клинично изпитванеClinicalTrials.gov· PHASE3 · RECRUITING
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and if people who take sacituzumab tirumotecan with or without bevacizumab live longer …
Merck Sharp & Dohme LLC
13 OCT
Клинично изпитванеClinicalTrials.gov· PHASE2 · NOT_YET_RECRUITING
Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer
This trial proposes to evaluate the immunologic and potential clinical effectiveness of intensive locoregional sequential intraperitoneal (IP) cisplatin (IPC) with intravenous (iv) paclitaxel followed by peritoneal in…
Kalinski, Pawel, MD, PhD
13 OCT
Клинично изпитванеClinicalTrials.gov· PHASE2 · RECRUITING
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific laboratory tests to help improve participants' ability to register to clinical trials throughout the…
National Cancer Institute (NCI)
13 OCT
Клинично изпитванеClinicalTrials.gov· PHASE2 · RECRUITING
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Patients with with recurrent or progressive medulloblastoma, ependymoma, atypical teratoid rhabdoid tumor (ATRT), and CNS tumors of various histologies have a very poor prognosis whether treated with conventional chem…
Medical University of Vienna
13 OCT
Клинично изпитванеClinicalTrials.gov· PHASE2 · NOT_YET_RECRUITING
A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)
The purpose of this study is to assess the safety, tolerability, and surgical feasibility of preoperative Pumitamig-based therapy and other molecules in resectable, Early-Stage Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Последни изследванияБЕЛЕЖКИ ОТ ПРАКТИКАТА · АНАЛИЗ
Analytical Science
Novo Nordisk Study Finds Follow-On Liraglutide Less Physically Stable Than Originator
Clinical Research
Genetic Analysis Argues for Lower GIP While Tirzepatide Agonises the Receptor
Regulatory
Consensus Statements Fill the GLP-1 Evidence Gap Regulators Have Not
Clinical Research
Low-Dose Tirzepatide Matched 5 mg on Weight Loss in a 112-Patient Japanese Cohort
Clinical Research
Semaglutide Withdrawal Trial Asks Whether Tapering Beats Stopping Cold
24 compounds·€/g·ECB · EUR/USD 1.1188·Updated 07:59 CET·Q4 2026
/ 04 Методология
Пълна методология →Как се изгражда данните/ източник · преобразуване · обновяване
M · 01
Данни от реална търговия
Всяка спот цена произтича от реални поръчки, движещи се през търговската мрежа на ViraChem в ЕС — не от анкети и не от извличане на ценоразписи.
Източник →M · 02EUR по курс на ЕЦБ
Сделките извън евро се привеждат в евро по дневния референтен курс на ЕЦБ за съответната дата на търговия. Една и съща конвенция за всички спот цени.
Преобразуване →M · 03Обновяване на всеки час
Спот цените, измененията на тенденциите и редовете на тикера се обновяват на всеки час. Всеки ред носи TTL, така че актуалността да е проверима надолу по веригата.
Честота →24 compounds·€/g·ECB · EUR/USD 1.1188·Updated 07:59 CET·Q4 2026
/ 05 Разгледайте
Разгледайте архива →Категории на изследванията/ 3 working lenses
CAT · 01→CAT · 02→CAT · 03→
Analytical Science
Characterisation, impurity profiling, and stability of peptide materials.
1
Статии
Clinical Research
Trial design, results, and pipeline movement in peptide therapeutics.
5
Статии
Regulatory
EMA, FDA and pharmacopoeial developments affecting peptide drug substance and product.
1
Статии
/ 06 Източници на данни
Europe PMCClinicalTrials.govUSPTObioRxivECB
Отворени регистри · дневно обновяване/ търговската платформаИскате да купите,
Искате да купите,
а не само да четете?
B2B уеб платформата — продуктов каталог, инструменти за запитвания (RFQ), аналитична документация и доставка в ЕС — се намира на virachemical.com.
Посетете virachemical.com/ какво правим
Готови формати, поръчково производство, пълнене и финиширане.
71 спецификации на класове в 11 категории — Pharma, Cosmetic, Food, Analytical, IVD, Cell culture, Industrial и други.
Вижте услугите/ заявка за оферта
Запитвания и оферти по обемни нива в рамките на 1 работен ден.
Кажете ни съединението, количеството и формата. Връщаме се с наличност, срок на доставка и доставна цена в ЕС.
Заявете оферта